The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Melanoma epidemiology, biology and prognosis
Open accessAbstract
Melanoma is a cancer arising from the malignant transformation of melanocytes. These pigment-producing cells derive embryologically from pluripotent neural crest stem cells. During foetal development they not only predominantly migrate to and differentiate within the epidermis, but also to other extra-cutaneous pigment-containing sites such as the eyes, meninges, oesophagus and mucous membranes. Three subtypes of melanoma can therefore be characterised: cutaneous melanoma (the most common) arising from melanocytes in the epidermis, mucosal melanoma from melanocytes residing in the mucous membranes and uveal melanoma from melanocytes residing in the ocular stroma. In this chapter we will consider each of these melanoma subtypes in turn, highlighting the differences in epidemiology, biology and prognosis between them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · cited 2×
“During the normal cell cycle, CDK4 complexes with cyclin D, resulting in phosphorylation of the retinoblastoma (Rb1) protein, in turn releasing E2F-1 and thus allowing it to induce S-phase gene synthesis; p16 therefore acts as a negative regulator of the cell cycle [47,50].”
BackgroundDistinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Chang, A. E., Karnell, L. H., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8<1664::aid-cncr23>3.0.co;2-g · Cited by 1,663
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2009) · Nature · doi:10.1038/nature07586 · Cited by 1,623
Somatic Activation of KIT in Distinct Subtypes of Melanoma
Curtin, J. A., Busam, K., Pinkel, D., & Bastian, B. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2984 · Cited by 1,616
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Mutations in GNA11 in Uveal Melanoma
Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000584 · Cited by 1,476
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462
Melanocyte biology and skin pigmentation
Lin, J. Y., & Fisher, D. E. (2007) · Nature · doi:10.1038/nature05660 · Cited by 1,379
Rodríguez‐Sains, R. S., Bart, R. S., Kopf, A. W., & Hölzle, E. (1979) · Cited by 1,287
Neves, S. R., Ram, P. T., & Iyengar, R. (2002) · Science · doi:10.1126/science.1071550 · Cited by 1,286
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Singh, A. D., Turell, M. E., & Topham, A. K. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.040 · Cited by 1,267
Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma
Kujala, E., Ma¨kitie, T., & Kivela¨, T. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0538 · Cited by 1,045
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Long, G. V., Menzies, A. M., Nagrial, A. M., Haydu, L. E., Hamilton, A. L., Mann, G. J., Hughes, T. M., Thompson, J. F., Scolyer, R. A., & Kefford, R. F. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.4327 · Cited by 1,042
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
A review of human carcinogens--part D: radiation
El Ghissassi, F., Baan, R., Straif, K., Grosse, Y., Secretan, B., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70213-x · Cited by 900
The pathogenesis of melanoma induced by ultraviolet radiation
Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401707 · Cited by 876
Melanoma and sun exposure: An overview of published studies
Elwood, J. M., & Jopson, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971009)73:2<198::aid-ijc6>3.0.co;2-r · Cited by 791
Trends in Cancer Incidence, Survival and Mortality
Estève, J., & Coleman, M. (2009) · Husband and Reznek's Imaging in Oncology, Third Edition · doi:10.3109/9780415874984-2 · Cited by 761
Onken, M. D., Worley, L. A., Ehlers, J. P., & Harbour, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1750 · Cited by 750
Incidence of noncutaneous melanomas in the U.S.
McLaughlin, C. C., Wu, X., Jemal, A., Martin, H. J., Roche, L. M., & Chen, V. W. (2005) · Cancer · doi:10.1002/cncr.20866 · Cited by 739
Germline mutations in BAP1 predispose to melanocytic tumors
Wiesner, T., Obenauf, A. C., Murali, R., Fried, I., Griewank, K. G., Ulz, P., Windpassinger, C., Wackernagel, W., Loy, S., Wolf, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.910 · Cited by 725
Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 723
Kohler, B. A., Ward, E., McCarthy, B. J., Schymura, M. J., Ries, L. A. G., Eheman, C., Jemal, A., Anderson, R. N., Ajani, U. A., & Edwards, B. K. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr077 · Cited by 713
Determinants of BRAF Mutations in Primary Melanomas
Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg123 · Cited by 664 · cited 3×
“Unlike cutaneous melanoma, V600E BRAF or NRAS mutations are rare in mucosal melanoma [166,167].”
BackgroundKIT Gene Mutations and Copy Number in Melanoma Subtypes
Beadling, C., Jacobson-Dunlop, E., Hodi, F. S., Le, C., Warrick, A., Patterson, J., Town, A., Harlow, A., Cruz, F., Azar, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0575 · Cited by 646
Regulation of Raf-1 by Direct Feedback Phosphorylation
Dougherty, M. K., Müller, J., Ritt, D. A., Zhou, M., Zhou, X. Z., Copeland, T. D., Conrads, T. P., Veenstra, T. D., Lu, K. P., & Morrison, D. K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.055 · Cited by 633
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma
Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., Seddon, J., Tarbell, N., & Boice, J. D. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1121 · Cited by 568
The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer (2007) · International Journal of Cancer · doi:10.1002/ijc.22453 · Cited by 561
Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22
Cannon-Albright, L. A., Goldgar, D. E., Meyer, L. J., Lewis, C. M., Anderson, D. E., Fountain, J. W., Hegi, M. E., Wiseman, R. W., Petty, E. M., Bale, A. E., et al. (1992) · Science · doi:10.1126/science.1439824 · Cited by 524
Bastian, B. C., LeBoit, P. E., Hamm, H., Bröcker, E.-B., & Pinkel, D. (1998) · PubMed · Cited by 513
Malignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
Dual-specificity MAP kinase phosphatases (MKPs) and cancer
Keyse, S. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9123-1 · Cited by 490
Genetics of hair and skin color
Rees, J. L. (2003) · Annual Review of Genetics · doi:10.1146/annurev.genet.37.110801.143233 · Cited by 485
Incidence of Uveal Melanoma in Europe
Virgili, G., Gatta, G., Ciccolallo, L., Capocaccia, R., Biggeri, A., Crocetti, E., Lutz, J.-M., & Paci, E. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.032 · Cited by 482
Nishikawa, S., Kusakabe, M., Yoshinaga, K., Ogawa, M., Hayashi, S., Kunisada, T., Era, T., Sakakura, T., & Nishikawa, S. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07744.x · Cited by 465
Trends in cancer incidence and mortality
(1994) · Cancer Causes & Control · doi:10.1007/bf01830253 · Cited by 462
Genome-wide association study identifies three loci associated with melanoma risk
Bishop, D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E., Randerson-Moor, J., Aitken, J. F., Avril, M.-F., Azizi, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.411 · Cited by 462
Ultraviolet A and melanoma: A review
Wang, S. Q., Setlow, R., Berwick, M., Polsky, D., Marghoob, A. A., Kopf, A. W., & Bart, R. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114594 · Cited by 454
Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Timothy Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043802 · Cited by 453
Melanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
Whiteman, D. C., Watt, P., Purdie, D. M., Hughes, M. C., Hayward, N. K., & Green, A. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.806 · Cited by 449
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Ding, S., Byrd, D. R., Cascinelli, N., Cochran, A. J., Coit, D. G., Eggermont, A. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1627 · Cited by 410
Omholt, K., Platz, A., Kanter, L., Ringborg, U. K., & Hansson, J. (2003) · PubMed · Cited by 399
Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
Giebel, L. B., & Spritz, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8696 · Cited by 383
The risk of melanoma in association with long-term exposure to PUVA
Stern, R. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114576 · Cited by 370
Thompson, J. F., Soong, S.-J., Balch, C. M., Gershenwald, J. E., Ding, S., Coit, D. G., Flaherty, K. T., Gimotty, P. A., Johnson, T., Johnson, M. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5812 · Cited by 363
The prognostic significance of ulceration of cutaneous melanoma
Balch, C. M., Wilkerson, J. A., Murad, T. M., Soong, S.-J., Ingalls, A. L., & Maddox, W. A. (1980) · Cancer · doi:10.1002/1097-0142(19800615)45:12<3012::aid-cncr2820451223>3.0.co;2-o · Cited by 361
Indoor Tanning and Risk of Melanoma: A Case-Control Study in a Highly Exposed Population
Lazovich, D., Vogel, R. I., Berwick, M., Weinstock, M. A., Anderson, K. E., & Warshaw, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1249 · Cited by 353 · cited 1×
“[29] Lazovich D, Vogel RI, Berwick M, et al.”
BackgroundVasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma
Onken, M. D., Worley, L. A., Long, M. D., Duan, S., Council, M. L., Bowcock, A. M., & Harbour, J. W. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2145 · Cited by 346
THE EFFECT OF IMMUNOSUPPRESSION ON PRE-EXISTING CANCERS
PENN, I. (1993) · Transplantation · doi:10.1097/00007890-199304000-00011 · Cited by 340
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Carbone, M., Ferris, L. K., Baumann, F., Napolitano, A., Lum, C. A., Flores, E. G., Gaudino, G., Powers, A., Bryant-Greenwood, P., Krausz, T., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-179 · Cited by 323
Mutant V599EB-Raf Regulates Growth and Vascular Development of Malignant Melanoma Tumors
Sharma, A., Trivedi, N. R., Zimmerman, M. A., Tuveson, D. A., Smith, C. D., & Robertson, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2423 · Cited by 321
(1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/73.1.75 · Cited by 318
Homozygous deletions within human chromosome band 9p21 in melanoma.
Fountain, J. W., Karayiorgou, M., Ernstoff, M. S., Kirkwood, J. M., Vlock, D. R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A. N., & Lahti, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10557 · Cited by 315
The Antimicrobial Properties of Melanocytes, Melanosomes and Melanin and the Evolution of Black Skin
MACKINTOSH, J. A. (2001) · Journal of Theoretical Biology · doi:10.1006/jtbi.2001.2331 · Cited by 313
Active Ras induces heterodimerization of cRaf and BRaf.
Weber, C., Slupsky, J. R., Kalmes, H. A., & Rapp, U. R. (2001) · PubMed · Cited by 312
Lifetime Risks of Common Cancers Among Retinoblastoma Survivors
Fletcher, O., Easton, D., Anderson, K., Gilham, C., Jay, M., & Peto, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh058 · Cited by 312
MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations
Box, N. F., Duffy, D. L., Chen, W., Stark, M., Martin, N. G., Sturm, R. A., & Hayward, N. K. (2001) · The American Journal of Human Genetics · doi:10.1086/323412 · Cited by 310
Collaborative Ocular Melanoma Study Group
Fine, S. L. (1999) · Archives of Family Medicine · doi:10.1001/archfami.8.1.11-a · Cited by 305
MALIGNANT MELANOMA IN ORGAN ALLOGRAFT RECIPIENTS1,2
Penn, I. (1996) · Transplantation · doi:10.1097/00007890-199601270-00019 · Cited by 305
Patrick, R. J., Fenske, N. A., & Messina, J. L. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.017 · Cited by 302
What are melanocytes really doing all day long…?
Plonka, P. M., Passeron, T., Brenner, M., Tobin, D. J., Shibahara, S., Thomas, A., Slominski, A., Kadekaro, A. L., Hershkovitz, D., Peters, E., et al. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00912.x · Cited by 297
Wehrle-Haller, B., & Weston, J. A. (1995) · Development · doi:10.1242/dev.121.3.731 · Cited by 283
Whelan, A. J., Bartsch, D., & Goodfellow, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331505 · Cited by 280
The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1
Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A., & Dutta, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.046755 · Cited by 274
Loercher, A. E., Tank, E. M. H., Delston, R. B., & Harbour, J. W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410115 · Cited by 266
Njauw, C.-N. J., Kim, I., Piris, A., Gabree, M., Taylor, M., Lane, A. M., DeAngelis, M. M., Gragoudas, E., Duncan, L. M., & Tsao, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035295 · Cited by 254
Sunlight Exposure as Risk Factor for Intraocular Malignant Melanoma
Tucker, M. A., Shields, J. A., Hartge, P., Augsburger, J., Hoover, R. N., & Fraumeni, J. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509263131305 · Cited by 251
Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma
Kong, Y., Si, L., Zhu, Y., Xu, X., Corless, C. L., Flaherty, K. T., Li, L., Li, H., Sheng, X., Cui, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2346 · Cited by 251
Cust, A. E., Armstrong, B. K., Goumas, C., Jenkins, M. A., Schmid, H., Hopper, J. L., Kefford, R. F., Giles, G. G., Aitken, J. F., & Mann, G. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.25576 · Cited by 246
BRAF and NRAS mutations in melanoma and melanocytic nevi
Poynter, J. N., Elder, J. T., Fullen, D. R., Nair, R. P., Soengas, M. S., Johnson, T. M., Redman, B., Thomas, N. E., & Gruber, S. B. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000222600.73179.f3 · Cited by 245
Bastian, B. C., Kashani–Sabet, M., Hamm, H., Godfrey, T. E., Moore, D. H., Bröcker, E.-B., LeBoit, P. E., & Pinkel, D. (2000) · PubMed · Cited by 245
Burgi, A., Brodine, S., Wegner, S., Milazzo, M., Wallace, M. R., Spooner, K., Blazes, D. L., Agan, B. K., Armstrong, A., Fraser, S., et al. (2005) · Cancer · doi:10.1002/cncr.21334 · Cited by 234
Clinicopathological Features of and Risk Factors for Multiple Primary Melanomas
Ferrone, C. R. (2005) · JAMA · doi:10.1001/jama.294.13.1647 · Cited by 233
Safaee Ardekani, G., Jafarnejad, S. M., Tan, L., Saeedi, A., & Li, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047054 · Cited by 224
Common sequence variants on 20q11.22 confer melanoma susceptibility
Brown, K. M., MacGregor, S., Montgomery, G. W., Craig, D. W., Zhao, Z. Z., Iyadurai, K., K Henders, A., Homer, N., Campbell, M. J., Stark, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.163 · Cited by 223
Garbe, C., Büttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., Guggenmoos-Holzmann, I., Lechner, W., Lippold, A., Orfanos, C. E., et al. (1995) · Cancer · doi:10.1002/1097-0142(19950515)75:10<2484::aid-cncr2820751014>3.0.co;2-u · Cited by 221
BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity
Nishikawa, H., Wu, W., Koike, A., Kojima, R., Gomi, H., Fukuda, M., & Ohta, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3355 · Cited by 221
Forsea, A. M., del Marmol, V., de Vries, E., Bailey, E. E., & Geller, A. C. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11125.x · Cited by 220
Natali, P. G., Nicotra, M. R., Winkler, A. B., Cavaliere, R., Bigotti, A., & Ullrich, A. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520207 · Cited by 211
Green, A. C., Baade, P., Coory, M., Aitken, J. F., & Smithers, M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8561 · Cited by 206
Sun and Solarium Exposure and Melanoma Risk: Effects of Age, Pigmentary Characteristics, and Nevi
Veierød, M. B., Adami, H.-O., Lund, E., Armstrong, B. K., & Weiderpass, E. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0567 · Cited by 206
Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone, K., Belle, P. A. V., Elenitsas, R., & Elder, D. (1997) · PubMed · Cited by 206
Joosse, A., Collette, S., Suciu, S., Nijsten, T., Lejeune, F., Kleeberg, U. R., Coebergh, J. W. W., Eggermont, A. M. M., & de Vries, E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0584 · Cited by 189
Host Factors, UV Radiation, and Risk of Uveal Melanoma: A Case-Control Study
Seddon, J. M. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110090031 · Cited by 186
C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma
Rivera, R. S., Nagatsuka, H., Gunduz, M., Cengiz, B., Gunduz, E., Siar, C. H., Tsujigiwa, H., Tamamura, R., Han, K. N., & Nagai, N. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0524-2 · Cited by 177
Analysis of N- and K-Ras Mutations in the Distinctive Tumor Progression Phases of Melanoma
Stas, M., Degreef, H., Demunter, A., De Wolf-Peeters, C., & van den Oord, J. J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01601.x · Cited by 176
Garibyan, L., & Fisher, D. E. (2010) · Current Oncology Reports · doi:10.1007/s11912-010-0119-y · Cited by 166
Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors
Piepkorn, M. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104687 · Cited by 162
AXEIX, T., & HEDIN, C. A. (1982) · European Journal of Oral Sciences · doi:10.1111/j.1600-0722.1982.tb00760.x · Cited by 161
Case-Control Study of Malignant Melanoma in Washington State
White, E., Kirkpatrick, C. S., & Lee, J. A. H. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117092 · Cited by 152
Uveal melanoma in relation to ultraviolet light exposure and host factors.
Holly, E. A., Aston, D. A., Char, D. H., Kristiansen, J. J., & Ahn, D. K. (1990) · PubMed · Cited by 152
Sun exposure predicts risk of ocular melanoma in Australia
Vajdic, C. M., Kricker, A., Giblin, M., McKenzie, J. D., Aitken, J. F., Giles, G. G., & Armstrong, B. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10579 · Cited by 152
Démenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton‐Bishop, J., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E. M., Elder, D. E., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq363 · Cited by 147
Khalili, J. S., Yu, X., Wang, J., Hayes, B. C., Davies, M. A., Lizee, G. A., Esmaeli, B., & Woodman, S. E. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3227 · Cited by 147
Lev, S., Yarden, Y., & Givol, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49629-4 · Cited by 145
Nagore, E., Oliver, V., Estrada, R. B., Moreno-Picot, S., Insa, A., & Fortea, J. M. (2005) · Melanoma Research · doi:10.1097/00008390-200506000-00005 · Cited by 143
Monosomy 3 and isochromosome 8q in a uveal melanoma
Horsman, D. E., Sroka, H., Rootman, J., et al. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90090-w · Cited by 140
Risk Factors for Ocular Melanoma: Western Canada Melanoma Study 2 3
Gallagher, R. P., Elwood, M., Rootman, J., Spinelli, J. J., Hill, G. B., Threlfall, W. J., & Birdsell, J. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/74.4.775 · Cited by 138
Vascular Endothelial Growth Factor A in Eyes With Uveal Melanoma
Missotten, G. S. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.10.1428 · Cited by 137
Tumor Vascularity in the Prognostic Assessment of Primary Cutaneous Melanoma
Kashani–Sabet, M., Sagebiel, R. W., Ferreira, C. M. M., Nosrati, M., & Miller, J. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.082 · Cited by 134
Deregulation of the Rb and p53 Pathways in Uveal Melanoma
Brantley, M. A., & Harbour, J. W. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64817-1 · Cited by 131
Vascular Involvement in the Prognosis of Primary Cutaneous Melanoma
Kashani–Sabet, M., Sagebiel, R. W., Ferreira, C. M. M., Nosrati, M., & Miller, J. R. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.9.1169 · Cited by 129
Abdel‐Rahman, M. H., Yang, Y., Zhou, X.-P., Craig, E. L., Davidorf, F. H., & Eng, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2418 · Cited by 129
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes
Grabbe, J., Welker, P., Dippel, E., & Czarnetzki, B. M. (1994) · Archives of Dermatological Research · doi:10.1007/bf00370723 · Cited by 127
Ambient UV, personal sun exposure and risk of multiple primary melanomas
Kricker, A., Armstrong, B. K., Goumas, C., Litchfield, M. J., Begg, C. B., Hummer, A., Marrett, L. D., Theis, B., Millikan, R. C., Thomas, N. E., et al. (2007) · Cancer Causes & Control · doi:10.1007/s10552-006-0091-x · Cited by 126
Age as a prognostic factor in the malignant melanoma population
Austin, P. F., Cruse, C. W., Lyman, G. H., Schroer, K. R., Glass, F., & Reintgen, D. S. (1994) · Annals of Surgical Oncology · doi:10.1007/bf02303614 · Cited by 126
Boyd, S. R. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.448 · Cited by 126
Chatzinasiou, F., Lill, C. M., Kypreou, K. P., Stefanaki, I., Nicolaou, V., Spyrou, G. M., Εvangelou, Ε., Roehr, J. T., Kodela, E., Katsambas, A., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr219 · Cited by 125
Tarhini, A. A., Stuckert, J., Lee, S., Sander, C., & Kirkwood, J. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1777 · Cited by 114
Berwick, M., Orlow, I., Hummer, A., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton‐Culver, H., Zanetti, R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0270 · Cited by 114
Increased Cancer Mortality Following a History of Nonmelanoma Skin Cancer
Kahn, H. S., Tatham, L. M., Patel, A. V., Thun, M. J., & Heath, C. W. (1998) · JAMA · doi:10.1001/jama.280.10.910 · Cited by 110
Nelemans, P. J., Groenendal, H., Kiemeney, L. A. L. M., Rampen, F. H. J., Ruiter, D. J., & Verbeek, A. L. M. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101252 · Cited by 103
Prescher, G., Bornfeld, N., Friedrichs, W., Seeber, S., & Becher, R. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00165-8 · Cited by 102
Moreau, S., Saïag, P., Aegerter, P., Bosset, D., Longvert, C., Hélias‐Rodzewicz, Z., Marin, C., Peschaud, F., Chagnon, S., Zimmermann, U., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2457-5 · Cited by 102
Molven, A., Grimstvedt, M. B., Steine, S. J., Harland, M., Avril, M., Hayward, N. K., & Akslen, L. A. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20202 · Cited by 100
Lee, D.-H., & Pfeifer, G. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212696200 · Cited by 99
Mallone, S., de Vries, E., Guzzo, M., Midena, E., Verne, J., Coebergh, J. W. W., Marcos‐Gragera, R., Ardanáz, E., Martínez, R., Chirlaque, M. D., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.004 · Cited by 98
Marghoob, A. A., Slade, J., Salopek, T. G., Kopf, A. W., Bart, R. S., & Rigel, D. S. (1995) · Cancer · doi:10.1002/1097-0142(19950115)75:2+<707::aid-cncr2820751415>3.0.co;2-w · Cited by 96
Melanoma underreporting: Why does it happen, how big is the problem, and how do we fix it?
Cockburn, M., Swetter, S. M., Peng, D., Keegan, T. H. M., Deapen, D., & Clarke, C. A. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.08.007 · Cited by 91
Wu, X., Li, J., Zhu, M. J., Fletcher, J. A., & Hodi, F. S. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0121 · Cited by 91
Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis
Olsen, C. M., Zens, M. S., Stukel, T. A., Sacerdote, C., Chang, Y., Armstrong, B. K., Bataille, V. A., Berwick, M., Elwood, M., Holly, E. A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24011 · Cited by 87
Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review
Måsbäck, A., Olsson, H. L., Westerdahl, J., Ingvar, C., & Jonsson, N. (2001) · Melanoma Research · doi:10.1097/00008390-200110000-00001 · Cited by 85
Ultraviolet light exposure as a risk factor for ocular melanoma in Queensland, Australia
Pane, A., & Hirst, L. W. (2000) · Ophthalmic Epidemiology · doi:10.1076/0928-6586(200009)731-vft159 · Cited by 85
c-Kit mutants require hypoxia-inducible factor 1α to transform melanocytes
Monsel, G., Ortonne, N., Bagot, M., Bensussan, A., & Dumaz, N. (2009) · Oncogene · doi:10.1038/onc.2009.320 · Cited by 79
Seddon, J. M. (1987) · Archives of Ophthalmology · doi:10.1001/archopht.1987.01060060087039 · Cited by 79
Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin
Coté, T. R., & Sobin, L. H. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e32831ef262 · Cited by 79
Regulation of VEGF-A in Uveal Melanoma
el Filali, M., Missotten, G. S., Maat, W., Ly, L. V., Luyten, G. P. M., van der Velden, P. A., & Jager, M. J. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4739 · Cited by 77
Brantley, M. A., & Harbour, J. W. (2000) · PubMed · Cited by 77
Pennello, G. A., Devesa, S. S., & Gail, M. H. (2000) · PubMed · Cited by 71
Color as a Risk Factor in Iris Melanoma
Rootman, J., & Gallagher, R. P. (1984) · American Journal of Ophthalmology · doi:10.1016/0002-9394(84)90240-x · Cited by 70
Lu, Y., Zhu, W., Tan, C., Yu, G., & Gu, J. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02065.x · Cited by 69
Lymphatic Invasion Is Independently Prognostic of Metastasis in Primary Cutaneous Melanoma
Xu, X., Chen, L., Guerry, D., Dawson, P., Hwang, W., VanBelle, P., Elder, D. E., Zhang, P. J., Ming, M. E., Schuchter, L. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0490 · Cited by 69
Migration and death from malignant melanoma
Cooke, K. R., & Fraser, J. D. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910360208 · Cited by 69
Tovo, L. F. R., Belfort, F. A., & Sanches, J. A. (2005) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302005000100010 · Cited by 66
van Dijk, M., Sprenger, S. H. E., Rombout, P. D. M., Marres, H. A. M., Kaanders, J. H. A. M., Jeuken, J. W. M., & Ruiter, D. J. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10156 · Cited by 64
Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand
Bulliard, J., Cox, B., & Elwood, M. (1994) · Cancer Causes & Control · doi:10.1007/bf01830242 · Cited by 63
KUO, P. K., Puliafito, C. A., WANG, K. M., LIU, H. S., & WU, B. F. (1982) · International Ophthalmology Clinics · doi:10.1097/00004397-198202230-00007 · Cited by 63
Ambient UVB and Melanoma Risk in the United States: A Case-Control Analysis
Lea, C. S., Scotto, J., Buffler, P. A., Fine, J., Barnhill, R. L., & Berwick, M. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.01.030 · Cited by 56
Ocular malignant melanoma in South African blacks.
Miller, B., Abrahams, C., COLE, G., & Proctor, N. S. F. (1981) · British Journal of Ophthalmology · doi:10.1136/bjo.65.10.720 · Cited by 45
Rivers, J. K., & Rivers, J. K. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90873-9 · Cited by 43
Lundberg, R., Brytting, M., Dahlgren, L., Kanter‐Lewensohn, L. R., Schloss, L., Dalianis, T., & Ragnarsson-Olding, B. K. (2006) · PubMed · Cited by 33
Crafting a Melanoma Educational Campaign to Reach Middle-Aged and Older Men
Geller, J., Swetter, S. M., Leyson, J., Miller, D. R., Brooks, K. R., & Geller, A. C. (2006) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2006.00066 · Cited by 23
Kraemer, K. H. (1994) · Archives of Dermatology · doi:10.1001/archderm.1994.01690080084012 · Cited by 1
Cited by
Pharmacological Update Properties of Aloe Vera and its Major Active Constituents
Sánchez, M., González-Burgos, E., Iglesias, I., & Gómez-Serranillos, M. P. (2020) · Molecules · doi:10.3390/molecules25061324 · Cited by 589
Cutaneous melanoma: From pathogenesis to therapy (Review)
Leonardi, G., Falzone, L., Salemi, R., Zangh�, A., Spandidos, D., Mccubrey, J., Candido, S., & Libra, M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4287 · Cited by 588
Comes, M. C., Fucci, L., Mele, F., Bove, S., Cristofaro, C., De Risi, I., Fanizzi, A., Milella, M., Strippoli, S., Zito, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24315-1 · Cited by 33
Peng, Y., Chu, Y., Chen, Z., Zhou, W., Wan, S., Xiao, Y., Zhang, Y., & Li, J. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-01909-5 · Cited by 21
Sun, Q., Novak, D., Hüser, L., Poelchen, J., Wu, H., Granados, K., Federico, A., Liu, K., Steinfass, T., Vierthaler, M., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33591 · Cited by 20
Metadata
- Authors
- Ali, Z., Yousaf, N., & Larkin, J.
- Venue
- European Journal of Cancer Supplements
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 11
- Issue
- 2
- Pages
- 81-91
- ISSN
- 1359-6349 (ISSN-L)
- OpenAlex
- W2015583071
- Cited by
- 278
- References
- 156
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.